Edge Therapeutics, Inc.
Biotechnology ResearchNew Jersey, United States2-10 Employees
Edge Therapeutics, Inc. is a clinical-stage biotechnology company based in Berkeley Heights, New Jersey. It focuses on discovering and developing hospital-based therapies intended to transform treatment approaches for acute, life-threatening neurological conditions, with the aim of bringing new options to clinical care in hospital settings. The company operates within the biotechnology research sector, seeking to advance therapies through clinical development with the goal of enabling new management paradigms for critical brain-related conditions. Its activities are positioned around developing novel interventions for acute neurological emergencies, and it has engaged in partnerships and corporate activity with other biotech entities in its recent history. In late 2018, Edge Therapeutics was involved in a merger process with PDS Biotechnology Corporation, signaling a strategic corporate transition during that period. The organization is relatively small in size, and its operations are centered in the United States.
1-888-653-2347 
support@leadiq.com 
